1224. Outcomes of Empirical Vancomycin De-escalation Based on Methicillin-Resistant Staphylococcus aureus Nares

BACKGROUND: Vancomycin is a first-line therapy for methicillin-resistant Staphylococcus aureus (MRSA) infections. Studies found that vancomycin is associated with a higher incidence of nephrotoxicity, even within therapeutic range. MRSA nares screening allows for rapid identification of MRSA carrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiachen, Chan, Arthur, Wattengel, Bethany A, Mergenhagen, Kari A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677569/
http://dx.doi.org/10.1093/ofid/ofad500.1064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677569/
http://dx.doi.org/10.1093/ofid/ofad500.1064

Ejemplares similares